Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anticonvulsant use during lactation.

S Hägg1, O Spigset

  • 1Division of Clinical Pharmacology, Norrland University Hospital, Umeå, Sweden. staffan.hagg@pharm.umu.se

Drug Safety
|July 6, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Connections between cross-tissue and intra-tissue biomarkers of aging biology in older adults.

Epigenetics communications·2023
Same author

Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database.

Psychological medicine·2022
Same author

Body mass index and Mini Nutritional Assessment-Short Form as predictors of in-geriatric hospital mortality in older adults with COVID-19.

Clinical nutrition (Edinburgh, Scotland)·2021
Same author

Technological readiness and implementation of genomic-driven precision medicine for complex diseases.

Journal of internal medicine·2021
Same author

Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry·2021
Same author

Vascular risk factor control and adherence to secondary preventive medication after ischaemic stroke.

Journal of internal medicine·2020
Same journal

Implementation Aspects of a Medicines Shortage Policy Tool: Evidence from Australia's Serious Scarcity Substitution Instruments.

Drug safety·2026
Same journal

Availability and Communication of Risk Management Strategies for Pregnancy Category X Medicines across Australian Medicine Information Sources.

Drug safety·2026
Same journal

The Bidirectionality of Lawyer Reporting Bias in Disproportionality Analysis.

Drug safety·2026
Same journal

Safety of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: A Longitudinal Analysis.

Drug safety·2026
Same journal

Developing a Hierarchical Algorithm to Identify Pregnancies and Determine Gestational Age from Nationwide Linked Health Data in Taiwan.

Drug safety·2026
Same journal

Safety and Effectiveness of Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparin for Cancer-Associated Thrombosis: A Systematic Review and Meta-analysis.

Drug safety·2026
See all related articles

Prescribing anticonvulsant drugs during breastfeeding requires careful consideration due to limited data. Carbamazepine, valproic acid, and phenytoin are generally safe, while others need close infant monitoring.

Area of Science:

  • Pharmacology
  • Neonatal Medicine
  • Lactation Studies

Background:

  • Prescribing anticonvulsant drugs during lactation presents significant clinical challenges.
  • Limited data exists on drug transfer into breast milk and infant safety.
  • Assessing adverse drug reactions in infants poses methodological difficulties.

Purpose of the Study:

  • To review current knowledge on anticonvulsant drug use during breastfeeding.
  • To provide evidence-based recommendations for clinical practice.
  • To guide healthcare professionals in risk-benefit analyses.

Main Methods:

  • Literature review of available studies on anticonvulsant drugs and lactation.
  • Analysis of drug concentrations in breast milk and reported infant outcomes.

Related Experiment Videos

  • Synthesis of data to formulate clinical recommendations.

    • Main Results:

    • Carbamazepine, valproic acid (sodium valproate), and phenytoin are considered compatible with breastfeeding.
    • Ethosuximide, phenobarbital (phenobarbitone)/primidone, and long-term benzodiazepine use require close infant monitoring.
    • Limited data necessitates caution with new-generation anticonvulsants, recommending infant monitoring.

    Conclusions:

    • Risk-benefit analysis is crucial when deciding on breastfeeding during anticonvulsant therapy.
    • Lowest effective maternal dosage and timing of breastfeeding can minimize infant exposure.
    • Continued breastfeeding offers significant advantages over formula feeding, supporting its continuation where feasible.